Mutation Rate of AmpC β-Lactamase–Producing Enterobacterales and Treatment in Clinical Practice: A Word of Caution
Clinical Infectious Diseases · 19.07.2024 · 79 (1) · 52-55
DOI: 10.1093/cid/ciae160 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 25.03.2024. Verfasst von Alexis Maillard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) and Sorbonne Université, Paris, France. Hauptthemen laut MEDLINE: beta-Lactamases, Bacterial Proteins, Anti-Bacterial Agents, Enterobacteriaceae. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
In a retrospective multicenter study of 575 patients with bloodstream infections or pneumonia due to wild-type AmpC β-lactamase–producing Enterobacterales, species with low in vitro mutation rates for AmpC derepression were associated with fewer treatment failures due to AmpC overproduction (adjusted hazard ratio, 0.5 [95% CI, .2–.9]). However, compared to cefepime/carbapenems, using third-generation cephalosporins as definitive therapy remained associated with this adverse outcome (15% vs 1%).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) and Sorbonne Université, Paris, France.
- Department of Bacteriology-Hygiene, Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, France.
- Faculty of Medicine, UMR-1184, Inserm, University Paris-Saclay, Le Kremlin-Bicêtre, France.
- French National Reference Center for Antimicrobial Resistance, Le Kremlin-Bicêtre, France.
- Clinical Research Unit, Annecy-Genevois Hospital, Epagny-Metz-Tessy, France.
- Department of Infectious Diseases, Saint-Louis Hospital, AP-HP, Paris, France.
ORCID-Profile: Alexis Maillard
Zitieren
APA
Maillard, A., Dortet, L., Delory, T., Lafaurie, M., Bleibtreu, A., & Treatment of AmpC producing Enterobacterales study group (2024). Mutation Rate of AmpC β-Lactamase–Producing Enterobacterales and Treatment in Clinical Practice: A Word of Caution. Clinical Infectious Diseases, 79(1), 52-55. https://doi.org/10.1093/cid/ciae160
Vancouver
Maillard A, Dortet L, Delory T, Lafaurie M, Bleibtreu A, Treatment of AmpC producing Enterobacterales study group. Mutation Rate of AmpC β-Lactamase–Producing Enterobacterales and Treatment in Clinical Practice: A Word of Caution. Clinical Infectious Diseases. 2024;79(1):52-55. doi:10.1093/cid/ciae160
BibTeX
@article{Maillard2024,
author = {Maillard, Alexis and Dortet, Laurent and Delory, Tristan and Lafaurie, Matthieu and Bleibtreu, Alexandre and Treatment of AmpC producing Enterobacterales study group, Treatment of AmpC producing Enterobacterales study group},
title = {Mutation Rate of AmpC β-Lactamase–Producing Enterobacterales and Treatment in Clinical Practice: A Word of Caution},
journal = {Clinical Infectious Diseases},
year = {2024},
volume = {79},
number = {1},
pages = {52--55},
doi = {10.1093/cid/ciae160}
}
EUVIMED